These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 18779825)
1. Functional expression of glucose-dependent insulinotropic polypeptide receptors is coupled to differentiation in a human adipocyte model. Weaver RE; Donnelly D; Wabitsch M; Grant PJ; Balmforth AJ Int J Obes (Lond); 2008 Nov; 32(11):1705-11. PubMed ID: 18779825 [TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes. Nie Y; Ma RC; Chan JC; Xu H; Xu G FASEB J; 2012 Jun; 26(6):2383-93. PubMed ID: 22366643 [TBL] [Abstract][Full Text] [Related]
4. Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance. Ceperuelo-Mallafré V; Duran X; Pachón G; Roche K; Garrido-Sánchez L; Vilarrasa N; Tinahones FJ; Vicente V; Pujol J; Vendrell J; Fernández-Veledo S J Clin Endocrinol Metab; 2014 May; 99(5):E908-19. PubMed ID: 24512489 [TBL] [Abstract][Full Text] [Related]
5. Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation. Kim SJ; Nian C; McIntosh CH J Lipid Res; 2011 Apr; 52(4):759-70. PubMed ID: 21245029 [TBL] [Abstract][Full Text] [Related]
6. Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies. Malavazos AE; Iacobellis G; Dozio E; Basilico S; Di Vincenzo A; Dubini C; Menicanti L; Vianello E; Meregalli C; Ruocco C; Ragni M; Secchi F; Spagnolo P; Castelvecchio S; Morricone L; Buscemi S; Giordano A; Goldberger JJ; Carruba M; Cinti S; Corsi Romanelli MM; Nisoli E Eur J Prev Cardiol; 2023 Jun; 30(8):680-693. PubMed ID: 36799940 [TBL] [Abstract][Full Text] [Related]
7. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice. Harada N; Yamada Y; Tsukiyama K; Yamada C; Nakamura Y; Mukai E; Hamasaki A; Liu X; Toyoda K; Seino Y; Inagaki N Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E61-8. PubMed ID: 17971513 [TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide enhances adipocyte development and glucose uptake in part through Akt activation. Song DH; Getty-Kaushik L; Tseng E; Simon J; Corkey BE; Wolfe MM Gastroenterology; 2007 Dec; 133(6):1796-805. PubMed ID: 18054552 [TBL] [Abstract][Full Text] [Related]
9. Functional GIP receptors are present on adipocytes. Yip RG; Boylan MO; Kieffer TJ; Wolfe MM Endocrinology; 1998 Sep; 139(9):4004-7. PubMed ID: 9724057 [TBL] [Abstract][Full Text] [Related]
18. Expression of glucose-dependent insulinotropic polypeptide and its receptor in the rat major salivary glands. Privatananupunt J; Watari I; Podyma-Inoue KA; Kubono M; Ono T Acta Histochem; 2014 May; 116(4):545-50. PubMed ID: 24360021 [TBL] [Abstract][Full Text] [Related]
19. GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial. Gögebakan Ö; Osterhoff MA; Schüler R; Pivovarova O; Kruse M; Seltmann AC; Mosig AS; Rudovich N; Nauck M; Pfeiffer AF Diabetologia; 2015 Aug; 58(8):1759-68. PubMed ID: 25994074 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of glucose-dependent insulinotropic polypeptide and its receptor in the retina of streptozotocin-induced diabetic rats. Cho GJ; Ryu S; Kim YH; Kim YS; Cheon EW; Park JM; Kim HJ; Kang SS; Choi WS Curr Eye Res; 2002 Dec; 25(6):381-8. PubMed ID: 12789546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]